JMP Securities Maintains Market Outperform on Privia Health Gr, Raises Price Target to $30
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
JMP Securities analyst David M. Scharf maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the price target from $29 to $30.
JMP Securities analyst David M. Scharf maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the price target from $29 to $30.